Concepedia

Daniel Russell

DR

11

Publications

398

Citations

11

H-Index

1986

Active since

Affiliations

AstraZeneca (United States)(Current)

AstraZeneca (United Kingdom)

University of California, Berkeley

Lawrence Berkeley National Laboratory

Daniel Russell is an author at AstraZeneca (United States) specializing in drug discovery, medicine, and natural sciences.

Top concepts

Publications per year

1986–2016

11

Publications

11

Structure-based design of protein tyrosine phosphatase-1B inhibitors

Emma Black, J. Breed, Alexander L. Breeze et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 75 citations · Full text

, , +5

Studies of chemical reactivity in the condensed phase. II. Vibrational relaxation of iodine in liquid xenon following geminate recombination

M. E. Paige, Daniel Russell, Charles B. Harris · The Journal of Chemical Physics · 1986 · 53 citations

, , +19

The applicability of binary collision theories to complex molecules in simple liquids

Karen E. Schultz, Daniel Russell, Charles B. Harris · The Journal of Chemical Physics · 1992 · 49 citations

, , +21

Potent and Selective Inhibitors of CK2 Kinase Identified through Structure-Guided Hybridization

James J. Dowling, Claudio Chuaqui, Timothy Pontz et al. · ACS Medicinal Chemistry Letters · 2012 · 47 citations · Full text

, , +18

Discovery of (+)-<i>N</i>-(3-Aminopropyl)-<i>N</i>-[1-(5-benzyl-3-methyl-4-oxo-[1,2]thiazolo[5,4-<i>d</i>]pyrimidin-6-yl)-2-methylpropyl]-4-methylbenzamide (AZD4877), a Kinesin Spindle Protein Inhibitor and Potential Anticancer Agent

Maria‐Elena Theoclitou, Brian Aquila, M. Block et al. · Journal of Medicinal Chemistry · 2011 · 43 citations · Full text

Rows per page

1–5 of 11